Key result
Anatomic-guided right ganglionated plexi ablation shortens RR intervals with ~0% bradyarrhythmia recurrence.
Why the study?
Endocardial ablation targeting atrial ganglionated plexi is an alternative for severe functional bradyarrhythmias, but no consensus exists on the best ablation strategy.
Does anatomic guided ablation of the atrial right ganglionated plexi improve parasympathetic modulation and prevent recurrence in patients with significant functional bradyarrhythmias?
Does anatomic guided ablation of the atrial right ganglionated plexi improve parasympathetic modulation and prevent recurrence in patients with significant functional bradyarrhythmias?
A simplified, purely anatomic-guided ablation of the right atrial ganglionated plexi effectively modulates cardiac autonomic tone and prevents symptom recurrence in patients with functional bradyarrhythmias.
Answers are grounded in this paper and cite their sources.
May increase heart rate without recurrence in functional bradyarrhythmias; hypothesis-generating pending randomized trials.
INTRODUCTION: Cardiac autonomic system modulation by endocardial ablation targeting atrial ganglionated plexi (GP) is an alternative strategy in selected patients with severe functional bradyarrhythmias, although no consensus exists on the best ablation strategy. The aim of this study was to evaluate if a simplified approach by a purely anatomical guided ablation of just the atrial right GP is enough for the treatment of these patients. METHODS: We prospectively enrolled patients with significant functional bradyarrhythmias and performed endocardial ablation purely guided by 3D electroanatomic mapping directed at the atrial right GP and accessed parameters of parasympathetic modulation and recurrence of bradyarrhythmias. RESULTS: Thirteen patients enrolled (76.9% male, median age 51, 42-63 years). After ablation, a median RR interval shortening of 28.3 (25.6-40.3)% occurred (1111, 937.5-1395.4 ms to 722.9, 652.2-882.4 ms, p = 0.0002). The AH interval also shortened (19, 10.5-35.7%) significantly after the procedure (115, 105-122 ms to 85, 71-105 ms, p = 0.0023) as well as Wenckebach cycle length (11.1, 5.9-17.8% shortening) from 450, 440-510 ms to 430, 400-460 ms, p = 0.0127. On 24-h Holter monitoring there was significant increase in heart rates (HR) of patients after ablation (minimal HR increased from 34 (26-43)bpm to 49 (43-56)bpm, p = 0,0102 and mean HR from 65 (47-72)bpm to 78 (67-87)bpm, p = 0.0004). No patients had recurrence of symptoms or significant bradyarrhythmias during a median follow-up of 8.4 months. CONCLUSIONS: A purely anatomic guided procedure directed only at the atrial right ganglionated plexi seems to be enough as a therapeutic approach for cardioneuroablation in selected patients with significant functional bradyarrhythmias.
No takes yet. Share an insight, caveat, or question.
Mesquita et al. (2021) studied significant functional bradyarrhythmias (n=13). Anatomic guided ablation of the atrial right ganglionated plexi was evaluated on recurrence of symptoms or significant bradyarrhythmias. Anatomic guided ablation of the atrial right ganglionated plexi shortened RR intervals and increased mean heart rate, with no bradyarrhythmia recurrence over 8.4 months.
Synapse has enriched 10 related papers. Consider them for comparative context: